Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Minireview: GNAS: normal and abnormal functions.

Lee S Weinstein1, Jie Liu, Akio Sakamoto

  • 1Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA. leew@amb.niddk.nih.gov

Endocrinology
|August 28, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Utility of <sup>68</sup>Ga-DOTATOC Positron Emission Tomography/Computed Tomography in Evaluating Metastatic Lesions of Clear Cell Renal Cell Carcinoma: A Case Report.

IJU case reports·2026
Same author

Local bicarbonate ringer's therapy after resection of idiopathic solitary tumoural calcinosis.

Journal of surgical case reports·2026
Same author

A Case of Secondary Chondrosarcoma Arising in Osteochondroma Diagnosed With 18 F-FDG PET/CT.

Clinical nuclear medicine·2026
Same author

Maintaining lung volume in a chest wall deformity after chest wall reconstruction.

Journal of thoracic disease·2025
Same author

Long-term functional and quality of life outcomes after cementless minimally invasive extendable endoprosthesis replacement in skeletally immature patients with bone sarcomas at the lower limb : a Japanese Musculoskeletal Oncology Group (JMOG) study.

Bone & joint open·2025
Same author

Complete Resection of Cardiac Metastasis Myxoid Liposarcoma.

Surgical case reports·2025
Same journal

Zingerone ameliorates ovarian impairment by regulating steroidogenesis and apoptosis in letrozole-treated mouse.

Endocrinology·2026
Same journal

Loss of the calorie restriction response protein DEPP1 worsens diet-induced obesity.

Endocrinology·2026
Same journal

Long noncoding RNAs mediate endocrine signaling and resistance in prostate cancer.

Endocrinology·2026
Same journal

Repeated Chemogenetic Activation of C1 Catecholamine Neurons Reduces Subsequent Glucoprivic Responses and Mimics HAAF.

Endocrinology·2026
Same journal

Postnatal exposure to maternal hypothyroidism leads to developmental delay and metabolic dysregulations in male mice.

Endocrinology·2026
Same journal

Discovery proteomics identification of factors contributing to gonadotropin β expression.

Endocrinology·2026
See all related articles

The GNAS gene controls G protein alpha-subunit (G(s)alpha) production, crucial for cellular signaling. Mutations and imprinting defects in GNAS cause Albright hereditary osteodystrophy and pseudohypoparathyroidism, impacting hormone resistance and bone development.

Area of Science:

  • Genetics
  • Endocrinology
  • Molecular Biology

Background:

  • The GNAS gene encodes the G protein alpha-subunit (G(s)alpha), essential for signal transduction via cAMP.
  • GNAS imprinting is tissue-specific, with maternal allele expression dominant in several endocrine tissues.
  • Disruptions in GNAS imprinting and mutations are linked to Albright hereditary osteodystrophy (AHO) and pseudohypoparathyroidism (PHP).

Purpose of the Study:

  • To elucidate the role of GNAS gene imprinting in endocrine disorders.
  • To differentiate between pseudohypoparathyroidism type 1A and 1B based on GNAS imprinting defects.
  • To investigate the impact of GNAS mutations and imprinting errors on G(s)alpha function and associated syndromes.

Main Methods:

  • Analysis of GNAS imprinting patterns in patients with AHO and PHP.

Related Experiment Videos

  • Genetic sequencing to identify mutations in the GNAS gene and regulatory regions.
  • Comparison of maternal and paternal allele expression in affected tissues.
  • Utilizing mouse knockout models to study G(s)alpha and XLalphas function.

    • Main Results:

    • Maternally inherited GNAS mutations cause AHO with hormone resistance (PHP1A).
    • Paternally inherited GNAS mutations lead to AHO alone.
    • GNAS imprinting defects, specifically loss of methylation in a key region, characterize PHP type 1B, causing hormone resistance without AHO.
    • Familial PHP1B is linked to mutations disrupting maternal imprint establishment.

    Conclusions:

    • GNAS imprinting is critical for normal endocrine function and development.
    • Distinct GNAS mutation and imprinting patterns explain the different clinical phenotypes of PHP type 1A and 1B.
    • Imprinting defects in GNAS are a significant cause of hormone resistance syndromes.